PHILADELPHIA, July 15, 2024 /PRNewswire/ -- Signant
Health, the leader in evidence generation for modern clinical
trials, announced today the appointment of Paul Richmond as Chief Commercial Officer. A
life sciences leader with over 20 years' experience working with
biopharma, biotech, and contract research organizations (CROs),
Paul's deep industry knowledge and expansive clinical network drove
the company's decision to select him as its new commercial
leader.
![Paul Richmond, Chief Commercial Officer, Signant Health Paul Richmond, Chief Commercial Officer, Signant Health](https://mma.prnewswire.com/media/2459831/Paul_Richmond_Signat_Health.jpg)
"I am exceptionally pleased to join Signant and lead the
commercial team during a time of increased emphasis on the role of
emerging biopharma, regulatory focus on patient-reported outcomes,
and accelerated adoption of technology throughout the clinical
trial lifecycle," said Paul. "Now, more than ever, trial sponsors
and CROs look to companies like Signant to ensure data quality
through comprehensive and integrated eclinical solutions. Our
recent launch of Signant Biotech further expands on a rich history
of supporting emerging biopharma companies, complemented by over 30
years of delivering evidence generation solutions for the world's
largest pharma organizations and CROs."
Paul joins Signant from global Contract Research Organization
(CRO) PPD, where he most recently served as senior vice president,
global head of commercial clinical research division. During his 14
years with the PPD group of companies, he held pivotal roles
including vice president of biotech as well as business development
positions at both PPD and its patient enrollment arm, Accelerated
Enrollment Solutions. Paul holds a PhD in organic chemistry from
the University of Durham, United
Kingdom.
"Having a seasoned industry leader like Paul in the role of
chief commercial officer is important not just for Signant, but
also for our customer mix of large and small sponsors, and CROs as
well," commented Roger Smith,
Signant's chief executive officer. "His vast, diverse expertise and
deep understanding of the complexities of our industry make him
exceptionally well-suited to guide our customers in selecting
solutions that are best suited to their protocol, disease area, and
evidence generation strategies. Paul fundamentally understands that
our customers want solutions that consistently capture high-quality
data required for in-trial decisions and regulatory submission. He
will be a great partner for them, and we are fortunate to add his
caliber to our leadership team."
To learn more about Signant Health and its full range of
eclinical solutions, visit:
https://www.signanthealth.com/
About Signant Health
Signant Health is the evidence
generation company. We are focused on leveraging software, deep
therapeutic and scientific knowledge, and operational expertise to
consistently capture, aggregate, and reveal quality evidence for
clinical studies across traditional, virtual, and hybrid trial
models. For more than 20 years, over 600 sponsors and CROs of all
sizes – including all Top 20 pharma – have trusted Signant
solutions for remote and site-based eCOA, EDC, eConsent, RTSM,
supply chain management, and data quality analytics. Learn more
at www.signanthealth.com.
Contact:
Heather Bilinski
media@signanthealth.com
+1 610.400.4141
Photo -
https://mma.prnewswire.com/media/2459831/Paul_Richmond_Signat_Health.jpg
Logo -
https://mma.prnewswire.com/media/1202052/Signant_Health_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/signant-health-appoints-20-year-life-sciences-veteran-paul-richmond-to-executive-leadership-team-as-chief-commercial-officer-302195379.html